Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
110,917,262
-
Number of holders
-
880
-
Total 13F shares, excl. options
-
98,907,864
-
Shares change
-
+2,628,119
-
Total reported value, excl. options
-
$14,924,035,182
-
Value change
-
+$390,470,581
-
Put/Call ratio
-
55%
-
Number of buys
-
374
-
Number of sells
-
-351
-
Price
-
$150.86
Significant Holders of QUEST DIAGNOSTICS INC - COMMON STOCK (DGX) as of Q4 2024
969 filings reported holding DGX - QUEST DIAGNOSTICS INC - COMMON STOCK as of Q4 2024.
QUEST DIAGNOSTICS INC - COMMON STOCK (DGX) has 880 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 98,907,864 shares
of 110,917,262 outstanding shares and own 89.17% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (13,960,458 shares), BlackRock, Inc. (10,124,677 shares), PRICE T ROWE ASSOCIATES INC /MD/ (5,490,278 shares), STATE STREET CORP (5,221,476 shares), VICTORY CAPITAL MANAGEMENT INC (3,359,986 shares), GEODE CAPITAL MANAGEMENT, LLC (2,690,021 shares), JPMORGAN CHASE & CO (2,433,913 shares), Davis Selected Advisers (2,397,260 shares), Grantham, Mayo, Van Otterloo & Co. LLC (2,268,990 shares), and DIMENSIONAL FUND ADVISORS LP (2,041,465 shares).
This table shows the top 880 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.